See more : Compagnie Financière Tradition SA (CFT.SW) Income Statement Analysis – Financial Results
Complete financial analysis of Dishman Carbogen Amcis Limited (DCAL.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Dishman Carbogen Amcis Limited, a leading company in the Biotechnology industry within the Healthcare sector.
- Control Bionics Limited (CBL.AX) Income Statement Analysis – Financial Results
- Xtract One Technologies Inc. (PTOTF) Income Statement Analysis – Financial Results
- First Republic Bank (FRC) Income Statement Analysis – Financial Results
- Milestone Furniture Limited (MILEFUR.BO) Income Statement Analysis – Financial Results
- Adslot Limited (ADS.AX) Income Statement Analysis – Financial Results
Dishman Carbogen Amcis Limited (DCAL.NS)
About Dishman Carbogen Amcis Limited
Dishman Carbogen Amcis Limited provides contract research and manufacturing services to the pharmaceutical industry worldwide. The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments. It also manufactures and supplies bulk drugs, intermediates, phase transfer catalysts, quaternary ammonium compounds, phosphoranes, wittig reagents, vitamin D products, fine chemicals, hand and body wash, sanitisers, antiseptics, and various pharmaceutical and cosmetic-related products, as well as generic and highly potent active pharmaceutical ingredients. The company was incorporated in 1983 and is headquartered in Ahmedabad, India. Dishman Carbogen Amcis Limited is a subsidiary of Adimans Technologies LLP.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 25.44B | 24.13B | 21.41B | 19.12B | 20.44B | 20.59B | 16.95B | 17.14B | 15.96B | 15.75B | 13.85B | 12.72B | 11.24B | 9.91B | 9.15B | 10.62B | 8.03B | 5.79B | 2.77B |
| Cost of Revenue | 24.02B | 5.11B | 4.59B | 4.84B | 4.51B | 4.20B | 3.52B | 3.38B | 3.46B | 5.40B | 3.78B | 3.80B | 3.85B | 4.49B | 3.57B | 4.03B | 3.51B | 2.54B | 1.52B |
| Gross Profit | 1.42B | 19.02B | 16.82B | 14.28B | 15.93B | 16.39B | 13.43B | 13.76B | 12.50B | 10.36B | 10.07B | 8.92B | 7.40B | 5.41B | 5.58B | 6.59B | 4.52B | 3.25B | 1.25B |
| Gross Profit Ratio | 5.58% | 78.81% | 78.56% | 74.68% | 77.94% | 79.62% | 79.23% | 80.30% | 78.33% | 65.75% | 72.71% | 70.12% | 65.79% | 54.64% | 60.96% | 62.03% | 56.34% | 56.17% | 45.20% |
| Research & Development | 129.80M | 172.90M | 139.00M | 65.00M | 215.50M | 137.70M | 52.40M | 52.90M | 116.60M | 5.73M | 11.50M | 2.71M | 32.42M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.33B | 1.00B | 721.60M | 630.90M | 557.60M | 731.30M | 495.70M | 613.60M | 493.60M | 405.86M | 321.25M | 265.46M | 1.32B | 987.42M | 1.00B | 1.24B | 841.96M | 689.65M | 262.86M |
| Selling & Marketing | 248.00M | 354.70M | 294.40M | 219.40M | 57.80M | 51.40M | 12.70M | 522.10M | 74.70M | 147.70M | 133.43M | 129.39M | 185.44M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.39B | 1.36B | 1.02B | 850.30M | 615.40M | 782.70M | 508.40M | 1.14B | 568.30M | 553.56M | 454.67M | 394.86M | 1.51B | 987.42M | 1.00B | 1.24B | 841.96M | 689.65M | 262.86M |
| Other Expenses | 157.10M | 277.70M | 195.00M | 141.60M | 191.60M | 269.60M | 295.50M | 20.80M | 23.90M | 456.33M | 371.00K | 6.42B | -3.85M | 3.09B | 24.94M | 59.15M | 15.72M | 94.33M | 3.27M |
| Operating Expenses | 19.32B | 18.50B | 16.52B | 14.40B | 13.35B | 13.03B | 10.91B | 11.28B | 9.48B | 8.61B | 7.87B | 6.82B | 5.82B | 4.08B | 4.15B | 4.61B | 3.47B | 2.36B | 726.58M |
| Cost & Expenses | 26.22B | 23.61B | 21.11B | 19.24B | 17.86B | 17.23B | 14.43B | 14.66B | 12.94B | 14.01B | 11.65B | 10.62B | 9.66B | 8.57B | 7.72B | 8.65B | 6.97B | 4.90B | 2.25B |
| Interest Income | 78.30M | 182.50M | 191.50M | 217.70M | 253.00M | 138.60M | 83.20M | 125.20M | 98.20M | 171.53M | 201.61M | 153.26M | 120.14M | 135.63M | 92.59M | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 1.13B | 856.90M | 392.20M | 390.30M | 487.70M | 419.80M | 425.60M | 384.60M | 682.90M | 790.92M | 707.01M | 728.04M | 729.44M | 557.34M | 480.26M | 493.54M | 339.10M | 189.43M | 102.01M |
| Depreciation & Amortization | 3.11B | 2.81B | 3.08B | 3.08B | 2.83B | 2.40B | 2.11B | 2.15B | 1.09B | 1.51B | 1.09B | 838.38M | 765.25M | 687.63M | 594.16M | 629.13M | 471.85M | 266.24M | 122.31M |
| EBITDA | 3.07B | 3.08B | 3.51B | 2.86B | 5.42B | 5.98B | 4.91B | 4.79B | 4.37B | 4.00B | 3.57B | 3.08B | 2.35B | 2.16B | 2.31B | 2.62B | 1.53B | 1.15B | 649.75M |
| EBITDA Ratio | 12.08% | 14.92% | 16.55% | 16.05% | 27.43% | 28.56% | 28.52% | 27.56% | 25.60% | 24.68% | 24.56% | 23.61% | 21.95% | 20.43% | 22.29% | 24.63% | 18.02% | 19.78% | 23.43% |
| Operating Income | -478.60M | 1.52B | 1.19B | 709.10M | 3.21B | 3.36B | 2.51B | 2.48B | 3.03B | 1.75B | 2.20B | 2.10B | 1.58B | 1.34B | 1.43B | 1.98B | 1.06B | 888.01M | 527.44M |
| Operating Income Ratio | -1.88% | 6.29% | 5.54% | 3.71% | 15.73% | 16.30% | 14.83% | 14.45% | 18.95% | 11.08% | 15.88% | 16.53% | 14.02% | 13.49% | 15.67% | 18.60% | 13.16% | 15.35% | 19.01% |
| Total Other Income/Expenses | -744.00M | -2.06B | -1.23B | -1.36B | -1.24B | -268.40M | -205.90M | -315.80M | -691.70M | -144.32M | -720.88M | -650.74M | -638.10M | -435.62M | -387.67M | -401.14M | 171.78M | 71.49M | 16.72M |
| Income Before Tax | -1.22B | -545.90M | -42.50M | -650.30M | 2.22B | 3.09B | 2.31B | 2.16B | 2.33B | 1.59B | 1.56B | 1.45B | 879.12M | 921.06M | 1.33B | 1.57B | 1.23B | 959.67M | 545.16M |
| Income Before Tax Ratio | -4.81% | -2.26% | -0.20% | -3.40% | 10.87% | 15.00% | 13.62% | 12.61% | 14.62% | 10.11% | 11.29% | 11.42% | 7.82% | 9.30% | 14.48% | 14.82% | 15.30% | 16.59% | 19.65% |
| Income Tax Expense | 311.90M | -247.90M | -222.60M | 1.00B | 417.80M | 984.60M | 762.20M | 706.50M | 623.60M | 394.38M | 471.30M | 449.90M | 311.53M | 107.62M | 149.53M | 103.91M | 10.88M | 29.56M | 30.22M |
| Net Income | -1.53B | -298.00M | 180.10M | -1.65B | 1.59B | 2.10B | 1.55B | 1.45B | 1.71B | 1.20B | 1.09B | 1.00B | 567.59M | 813.44M | 1.17B | 1.46B | 1.20B | 917.09M | 508.45M |
| Net Income Ratio | -6.03% | -1.24% | 0.84% | -8.64% | 7.76% | 10.22% | 9.12% | 8.49% | 10.72% | 7.61% | 7.89% | 7.88% | 5.05% | 8.21% | 12.82% | 13.76% | 14.91% | 15.85% | 18.33% |
| EPS | -9.79 | -1.90 | 1.15 | -10.53 | 9.85 | 13.03 | 9.58 | 9.01 | 10.60 | 7.43 | 6.77 | 6.22 | 3.52 | 4.96 | 7.28 | 9.07 | 7.85 | 6.58 | 3.70 |
| EPS Diluted | -9.79 | -1.90 | 1.15 | -10.53 | 9.85 | 13.03 | 9.58 | 9.01 | 10.60 | 7.43 | 6.77 | 6.22 | 3.52 | 4.96 | 7.22 | 8.99 | 7.35 | 5.66 | 3.16 |
| Weighted Avg Shares Out | 156.74M | 156.78M | 156.78M | 156.79M | 161.00M | 161.39M | 161.39M | 161.39M | 161.39M | 161.39M | 161.39M | 161.39M | 161.39M | 161.39M | 161.39M | 161.24M | 152.48M | 139.52M | 137.34M |
| Weighted Avg Shares Out (Dil) | 156.78M | 156.78M | 156.78M | 156.79M | 161.00M | 161.39M | 161.39M | 161.39M | 161.39M | 161.39M | 161.39M | 161.39M | 161.39M | 161.39M | 162.67M | 162.67M | 162.67M | 162.66M | 162.66M |
Source: https://incomestatements.info
Category: Stock Reports